HAL Id: hal-03165441
https://hal.archives-ouvertes.fr/hal-03165441
Submitted on 10 Mar 2021
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of
sci-entific research documents, whether they are
pub-lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d’enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.
Distributed under a Creative Commons Attribution - NonCommercial| 4.0 International
License
Physician Among Patients with Diabetes: A
Cross-Sectional Study
L. Halepian, M. B. Saleh, Souheil Hallit, L. R. Khabbaz
To cite this version:
L. Halepian, M. B. Saleh, Souheil Hallit, L. R. Khabbaz. Adherence to Insulin, Emotional Distress,
and Trust in Physician Among Patients with Diabetes: A Cross-Sectional Study. Diabetes Therapy,
Springer, 2018, 9 (2), pp.713-726. �10.1007/s13300-018-0389-1�. �hal-03165441�
ORIGINAL RESEARCH
Adherence to Insulin, Emotional Distress, and Trust
in Physician Among Patients with Diabetes:
A Cross-Sectional Study
Lucine Halepian.Mary Bou Saleh.Souheil Hallit .Lydia Rabbaa Khabbaz
Received: January 7, 2018 / Published online: March 8, 2018 Ó The Author(s) 2018. This article is an open access publication
ABSTRACT
Introduction: Type 2 diabetes represents a sig-nificant public health issue, with increasing prevalence in developing countries while adherence to insulin treatment remains a chal-lenge. No studies have evaluated the relation-ship between adherence to insulin, diabetes-related distress, and trust in physician among persons with diabetes. Our objectives were to evaluate treatment adherence to insulin,
emotional distress (using the Problem Areas in Diabetes Questionnaire, PAID), trust in physi-cian, and to examine associations between them among Lebanese patients with diabetes. Methods: This cross-sectional study, conducted in all districts of Lebanon between August 2016 and April 2017, enrolled 135 adult patients. Results: The mean percentage score of adher-ence to insulin was 79.7 ± 19.94. A significantly higher mean adherence score was found in non-sedentary (81.96) compared to sedentary patients (67.41) (p = 0.017), with no difference between gender, employment, rural vs non-rural residence, or familial history of diabetes. In addition, no significant relationship was seen between adherence score and education level, smoking, or alcohol intake. A significant positive association was found between trust in physician and adherence scores, whereas a significant but negative one was found between PAID and adherence scores. The results of linear regressions showed that a secondary level of education (beta = - 13.48) significantly decreased the trust in
Enhanced content To view enhanced content for this article go tohttps://doi.org/10.6084/m9.figshare. 5849904.
Electronic supplementary material The online version of this article (doi:https://doi.org/10.1007/ s13300-018-0389-1) contains supplementary material, which is available to authorized users.
Lucine Halepian and Mary Bou Saleh contributed equally to the manuscript.
Souheil Hallit and Lydia Rabbaa Khabbaz were last co-authors.
L. Halepian M. B. Saleh L. R. Khabbaz (&) Pharmacology, Clinical Pharmacy and Drug Quality Control Laboratory, Saint-Joseph University of Beirut, Beirut, Lebanon
e-mail: Lydia.khabbaz@usj.edu.lb L. Halepian M. B. Saleh S. Hallit (&) L. R. Khabbaz
Faculty of Pharmacy, Saint-Joseph University of Beirut, Beirut, Lebanon
e-mail: souheilhallit@hotmail.com
S. Hallit
Faculty of Pharmacy, Lebanese University, Beirut, Lebanon
S. Hallit
Faculty of Medicine and Medical Sciences, Holy Spirit University of Kaslik, Kaslik, Lebanon S. Hallit
Research Department, Psychiatric Hospital of the Cross, P.O. Box 60096, Jal Eddib, Lebanon
physician score, whereas the total number of oral antidiabetics (beta = 0.93) increased it. Having a sedentary lifestyle (beta = - 12.73) and smoking \3 waterpipes/week compared to no smoking (beta = - 16.82) significantly decreased the adherence score. Female gender (beta = 10.46), smoking \ 3 waterpipes (beta = 27.42) and 3 ? waterpipes/week (beta = 17.95) significantly increased the PAID score.
Conclusion: Trust in physician is associated with an increased adherence and with decreased diabetes-related distress. This distress was also associated with poor adherence in our study.
Keywords: Adherence; Diabetes; Emotional distress; Insulin; Trust in physician
INTRODUCTION
Every 6 s, a person dies in the world because of diabetes [1]. According to the latest report of the World Health Organization (WHO), type 2 dia-betes (T2D) will be the seventh leading cause of death by 2030 [2]. Also, T2D presents a partic-ularly high prevalence in both the Middle East and North Africa; among these regions, Leba-non occupies seventh place with a rate of 16.3% [1].
According to the WHO, adherence to treat-ment may be defined as the extent to which the patient’s history of therapeutic drug-taking coincides with the prescribed treatment [3]. Adherence to treatment remains a challenge in T2D since it is a chronic illness that is associated with a risk of comorbidity and requires a life-style change, especially after the onset of insu-lin therapy [4].
Even though insulin remains the most effective therapy to lower glycemia, the
American Diabetes Association and the National Institute for Health and Clinical Excellence (NICE) guidelines recommend using insulin as a last resort, after several failures to achieve glycemic control with an oral glucose-lowering agent [5–7].
Low insulin adherence leads to poor gly-cemic control and may exacerbate microvascu-lar and macrovascumicrovascu-lar complications such as kidney disease, dyslipidemia, stroke, retinopa-thy, nephroparetinopa-thy, and neuropathy and may increase episodes of hypoglycemia [8]. In fact, 45% of patients with T2D fail to achieve a good glycemic control [6].
Furthermore, according to several studies, diabetes may cause emotional distress which probably has an influence on medication adherence. Emotional distress is associated with depression, patient fears, and a lack of social and family support [9, 10].
In addition, trust in the healthcare provider is one of the central pillars of a patient–physi-cian relationship. Previous studies conducted among adults with diabetes showed that increased trust in one’s physician has been associated with better glycemic control [11,12]. The quality of information exchange and of primary care relationships are affected by the patient and provider communication behaviors [13]. In the short term, communicating with the patient can enhance trust in the physician, who will be able to incorporate treatment decisions according to the patient’s preferences and needs [13]. In addition, Schoenthaler et al. suggested that the quality of the patient–physician relationship has a strong influence on adherence to medication [14]. A better relationship contributes to the patients’ engagement in their care, which further influ-ences outcomes related to self-care [15]. Con-versely, when patients do not have confidence in their healthcare provider, they are less likely to implement care recommendations and thus to be adherent to their prescribed treatment [16].
Previous findings have suggested that high levels of diabetes-specific distress may account for higher functional impairment, work loss, and poorer self-management behavior [17–19]. Decreasing emotional distress is
S. Hallit
Occupational Health Environment Research Team, U1219 BPH Bordeaux Population Health Research Center Inserm, Universite´ de Bordeaux, Bordeaux, France
S. Hallit
INSPECT-LB: Institut National de Sante Publique, Epidemiologie Clinique et Toxicologie, Faculty of Public Health, Lebanese University, Beirut, Lebanon
important in helping the patient with diabetes to cope with the disease and improving adher-ence to treatment [3]. Furthermore, Fisher et al. [20] identified seven major sources of distress among patients with type 1 diabetes, among them physician distress. This finding led us to hypothesize that trust may be a factor that contributes to physician-related diabetes dis-tress, in type 1 as well as type 2 diabetes.
Several studies have been conducted to detect factors associated with insulin adherence worldwide [21–23], but none explored the impact of trust in physician and diabetes-related emotional distress on adherence to insulin. The primary objective of this study was to assess factors associated with insulin adherence among Lebanese patients with diabetes and to explore the relationship between this adher-ence, the patients’ trust in their healthcare provider, and diabetes-related emotional distress.
METHODS
Study Design and Population
This cross-sectional study, conducted in all dis-tricts of Lebanon, was done between August 2016 and April 2017. Our sample was con-structed from 20 community pharmacies selec-ted randomly. Adult patients from any gender, with type 2 diabetes diagnosed at least 3 months ago, and treated with insulin or insulin analogues were eligible. Patients using an insulin pump were excluded.
Data Collection
The questionnaire was distributed by trained interviewers. After obtaining the authorization from each pharmacy owner, the study objec-tives were explained to each patient after obtaining a written consent.
The self-administered anonymous question-naire was in Arabic, the native language in Lebanon; it was composed of different sections: the first part included sociodemographic (age, gender, place of residence, marital status, and
educational level), social habits (cigarette and waterpipe smoking, alcohol consumption), physical activity, family history of diabetes, duration and complications of diabetes. The second one comprised questions about insulin: name, dose, frequency of administration, shak-ing the vial or not before withdrawshak-ing, respecting the time of administration, storage, changing the needle after use, respecting the expiry date of the vial after opening; we also included questions about the level of patient’s fasting blood glucose (in the last checkup), the frequency of monitoring, the number of hypo-and/or hyperglycemia episodes during the last 12 months.
The scales used in this study (adherence, trust in physician, and PAID) were translated from English to Arabic through an initial translation and back-translation process. The English version was translated into Arabic by a certified translator, then this translation was translated again into English by another certi-fied translator. Upon completion of this pro-cess, the translators compared the English versions of the scales to determine whether the variables had the same meaning. The back translation did not lead to any modification in the Arabic version of any scale.
Adherence Assessment
The adherence to insulin was assessed using an adaptation of Lu et al.’s questionnaire [24] by asking the patients about the frequency, per-centage, and rating response of their insulin use during the last month. Concerning the fre-quency, we asked the patient ‘‘did you take insulin all the time?’’ with the possible respon-ses being divided as follow: 0% for none of the time, 20% for a little of the time, 40% for some of the time, 60% for a good bit of the time, 80% for most of the time, and 100% for all the time. The percentage item was checked using the question ‘‘what percent of the time were you able to take your medications exactly as your doctor prescribed them?’’ The rating item was assessed using the question ‘‘rate your ability to take all your medications as prescribed’’ with the possible answers being divided as follows:
0% = very poor, 20% = poor, 40% = fair, 60% = good, 80% = very good, and 100% = excellent. The total score was calcu-lated by summing all three answers and pre-sented in a percentage [24–26]. We calculated the reliability of each scale to assess the quality of our data. We obtained acceptable Cronbach alpha (0.621). Initially, the Lu et al.’s question-naire was validated among patients with HIV and was later used in a population of patients attending general practice [26].
Trust in Physician Scale
This scale is composed of 11 items (supple-mentary file), scored on a 5-point Likert scale ranging from 1 (strongly disagree) to 5 (strongly agree), except for questions 1, 5, 7, and 11 where the scoring was reversed. A summary measure of trust is obtained by taking the unweighted mean of the responses to the 11 questions and transforming that value to a
0–100 scale. Higher scores reflect greater trust. The wording of the 11 questions and the scoring system for each question are presented in Table1. This scale was largely used among dif-ferent participant populations and across a wide range of pathologies [27–30]. When completing the scale, respondents were instructed to think of the endocrinologist who usually provided their diabetes care [31]. We obtained high Cronbach alpha for this scale (0.892).
Problem Areas in Diabetes Questionnaire (PAID)
The PAID measures diabetes-related emotional distress, which correlates with measures of related concepts such as depression, social sup-port, health beliefs, and coping style, as well as predicts future blood glucose control of the patient [32]. The PAID is a self-report pencil and paper questionnaire that contains 20 items that describe negative emotions related to diabetes
Table 1 Trust in physician scale questions and scoring
Totally disagree
Disagree Neutral Agree Totally agree 1. I doubt that my doctor really cares about me as a person 5 4 3 2 1 2. My doctor is usually considerate of my needs and puts them first 1 2 3 4 5 3. I trust my doctor so much I always try to follow his/her advice 1 2 3 4 5 4. If my doctor tells me something is so, then it must be true 1 2 3 4 5 5. I sometimes distrust my doctor’s opinions and would like a second
one
5 4 3 2 1
6. I trust my doctor’s judgments about my medical care 1 2 3 4 5 7. I feel my doctor does not do everything he/she should about my
medical care
5 4 3 2 1
8. I trust my doctor to put my medical needs above all other considerations when treating my medical problems
1 2 3 4 5
9. My doctor is well qualified to manage (diagnose and treat or make an appropriate referral) medical problems like mine
1 2 3 4 5
10. I trust my doctor to tell me if a mistake was made about my treatment
1 2 3 4 5
11. I sometimes worry that my doctor may not keep the information we discuss totally private
(e.g., fear, anger, frustration) commonly expe-rienced by patients with diabetes. Completion takes approximately 5 min. Each question has five possible answers with a value from 0 to 4, with 0 representing ‘‘no problem’’ and 4 ‘‘a serious problem’’. The scores are added up and multiplied by 1.25, generating a total score between 0–100. Patients scoring 40 or higher may be at the level of ‘‘diabetes-related distress’’ and warrant special attention. An extremely low score (0–10) combined with poor glycemic control may be indicative of denial. The Cron-bach alpha for the PAID scale was excellent (0.909).
Compliance with Ethical Guidelines
The study protocol was approved by the ethics committee of Saint-Joseph University of Beirut (reference number: USJ-2016-55). All proce-dures performed in studies involving human participants were in accordance with the ethical standards of the institutional research commit-tee of Saint-Joseph University of Beirut and with the 1964 Declaration of Helsinki and its later amendments. Informed consent was obtained from all individual participants included in the study.
Statistical Analysis
Data were collected and processed by Statistical Package for the Social Sciences SPSS, Version 23. Categorical variables were presented in fre-quencies and percentages, and continuous variables as means with standard deviations. Statistical analysis was conducted using Chi square, Fisher exact t test, and analysis of vari-ance. ANOVA and Kruskal–Wallis tests were used to compare between three groups or more, and Pearson correlation coefficient was used to assess correlations between quantitative vari-ables. In addition, a multivariate regression was conducted to reduce confounders. A linear regression was performed taking the adherence to treatment as the dependent variable. Vari-ables which gave a p value less than 0.2 in the bivariate analysis were independent variables. A
p value less than 0.05 was considered significant.
RESULTS
Sociodemographic Characteristics of Patients
The total number of patients included in this study was 135 patients. The main sociodemo-graphic characteristics of patients are presented in Table2.
Data Related to Clinical Characteristics of Diabetes
The mean duration of diabetes, since diagnosis, was 229.50 months (more than 19 years). Seventy-one percent of patients had a family history of diabetes and 88% were followed by a specialist in endocrinology. Ninety-three per-cent of patients in this study had comorbidities with an average of two concurrent medical conditions associated with diabetes. The results are shown in Table3.
Data Related to Insulin Therapy
Information regarding insulin therapy is sum-marized in Table4. Six different patterns of insulin administration were observed. Most patients, about 76%, used the regimen based on the administration of a basal insulin alone or a basal insulin and bolus premix. The remaining patients were on other regimens. The majority of patients (79%) used insulin pens.
Thirteen percent of the patients were well controlled with an HbA1C \ 7%. Forty-nine percent were considered to be reasonably con-trolled with an HbA1C between 7% and 8%. Thirty-five percent were poorly controlled (HbA1c [ 8%).
Concerning the patient’s education, 88% of the patients gave a correct answer when asked about the normal range of fasting blood glucose and 84% knew the target levels of HbA1C that provide a good diabetes control (HBA1C \ 8%). Furthermore, 63% of these patients were
practicing a self-glucose monitoring test with an average frequency of once a day.
Average Scores Obtained for Trust
in Physician Scale, PAID, and Adherence to Insulin
The mean trust in physician score was 73.35 ± 20.38 (median = 75), whereas the mean PAID and adherence scores were 32.75 ± 29.37 (median = 22.41) and 79.7 ± 19.94 (me-dian = 87.5), respectively.
Bivariate Analysis
A significantly higher mean adherence score was found in non-sedentary (81.96) compared to sedentary patients (67.41). A significantly higher PAID score was found in female com-pared to male patients (37.27 vs 28.11), in sedentary compared to non-sedentary patients (42.38 vs 30.96). A significantly higher mean trust in physician score was found in illiterate patients (78.66) compared to other levels of education, and in those who smoked below three waterpipes weekly (55.35) compared to other groups (Table5).
Furthermore, a significant negative correla-tion was found between the trust in physician score and the PAID score (r = - 0.289) and a positive one with the adherence score Table 2 Patients’ sociodemographic characteristics
Sex
Male,N (%) 67 (49.6%) Female,N (%) 68 (50.4%) Age in years, mean (standard deviation) 65.84 (13.2) Weight in kg, mean (standard deviation) 76.92 (16.1)
BMI (body mass index), mean (standard deviation) 27.66 (5.5) Less than 18.5,N (%) 5 (3.7%) Between 18.5 and 24.9,N (%) 36 (26.7%) Between 25 and 29.9,N (%) 51 (37.8%) 30 or more,N (%) 43 (31.9%) Marital status Married,N (%) 98 (72.6%) Divorced/widower,N (%) 19 (14.1%) Single,N (%) 18 (13.3%) Sedentary lifestyle Yes,N (%) 21 (15.6%) No,N (%) 114 (84.4%) Residence Rural,N (%) 63 (46.7%) Non rural,N (%) 72 (53.3%) Working Yes,N (%) 41 (30.4%) No,N (%) 94 (69.6) Level of education Illiterate,N (%) 18 (13.3%) Primary,N (%) 56 (41.5%) Secondary,N (%) 26 (19.3%) University,N (%) 35 (25.9%) Cigarette consumption per day
Non-smoker,N (%) 64 (47.4%) 1–14 cigarettes,N (%) 14 (10.4%) 15 or more cigarettes,N (%) 25 (18.5%) Former smoker,N (%) 32 (23.7%)
Table 2 continued
Waterpipe consumption per week
Non-smoker,N (%) 110 (81.5%) Below 3, N (%) 7 (5.2%) 3 or more,N (%) 8 (5.9%) Former smoker, N (%) 10 (7.4%) Alcohol consumption per week
Non-drinker, N (%) 94 (69.6%) Up to one time,N (%) 26 (19.3%) More than once,N (%) 9 (6.7%) Former drinker,N (%) 6 (4.4%)
(r = 0.416). A significant negative correlation was found between the PAID score and the adherence score (r = - 0.3), duration of diabetes since diagnosis (r = - 0.172), and the duration of insulin therapy (r = - 0.239) (Table6).
Multivariable Analysis
The results of a first stepwise linear regression, taking the trust in physician score as the dependent variable, showed that a secondary level of education was significantly associated with a decrease in the trust in physician score (beta = - 13.48), whereas the total number of oral antidiabetics was significantly associated with an increase in that score (beta = 0.93).
A second stepwise linear regression, taking the adherence score as the dependent variable, showed that having a sedentary lifestyle (beta = - 12.739) and smoking less than three waterpipes per week compared to no waterpipe smoking (beta = - 16.826) were significantly
associated with a decrease in the adherence score.
A third stepwise linear regression, taking the PAID score as the dependent variable, showed that female gender (beta = 10.467), smoking less than three waterpipes (beta = 27.426), and three or more waterpipes weekly (beta = 17.951) compared to no waterpipe smoking were significantly associated with an increase in the PAID score (Table7).
DISCUSSION
To the best of our knowledge, our study is the first to assess the adherence of patients with diabetes type 2 to their insulin treatment and the factors associated with this adherence, in Lebanon. Adherence to treatment is a key Table 3 Clinical characteristics of diabetes among
participants
Diabetes duration in months, mean (standard deviation)
229.50 (126.02)
Family history of diabetes
Yes,N (%) 96 (71.1%) No,N (%) 39 (28.9%) Physician’s visit frequency
Mean number of visits/year (standard deviation)
4.59 (5.14)
Comorbidities, mean (standard deviation)
6.00 (2.95)
0 comorbidity, number of patients (%) 6 (4.4%) 1 comorbidity 3 (2.2%) 2 comorbidities 7 (5.2%) 3 comorbidities 9 (6.7%) 4 comorbidities 13 (9.6%) 5–9 comorbidities 81 (60.0%) 10? comorbidities 16 (11.7%)
Table 4 Diabetes treatment
Duration of therapy in months, mean (standard deviation)
85.74 (89.47)
Total daily dose in IU/kg, mean (standard deviation)
0.49 (0.33)
Delivery device
Pen,N (%) 107 (79.3%) Vial,N (%) 27 (20.0%) Pen and vial,N (%) 1 (0.7%) Types of insulin
One,N (%) 106 (78.5%) Two,N (%) 28 (20.75%) Three,N (%) 1 (0.75%) Number of insulin injection per day,
mean (standard deviation)
2.63 (1.69)
Concomitant use of oral antidiabetic drugs
Yes,N (%) 94 (69.6%) No,N (%) 41 (30.4%) Number of oral antidiabetic
drugs/participant, mean (standard deviation)
Table 5 Bivariate analysis of factors associated with the adherence to insulin, trust in physician, and PAID scores Variable Trust in physician score PAID score Adherence score Gender Male 71.43 ± 19.58 28.11 ± 22.75* 78.40 ± 20.66 Female 75.23 ± 21.11 37.27 ± 21.27* 80.97 ± 19.28 Sedentary lifestyle No 74.28 ± 20.67 30.96 ± 21.53* 81.96 ± 18.16* Yes 68.29 ± 18.33 42.38 ± 25.04* 67.41 ± 24.77* Residence Urban 74.77 ± 19.17 30.44 ± 20.30 81.90 ± 15.85 Rural 71.71 ± 21.71 35.35 ± 24.47 77.18 ± 23.66 Working status No 74.08 ± 20.35 32.24 ± 21.93 79.52 ± 20.57 Yes 71.67 ± 20.59 33.96 ± 23.72 80.10 ± 18.65 Family history of diabetes
No 73.83 ± 21.83 29.71 ± 24.12 84.77 ± 16.19** Yes 73.15 ± 19.87 34.01 ± 21.67 77.63 ± 21.01** Concomitant use of oral antidiabetics
No 73.66 ± 19.11 33.44 ± 23.12 78.96 ± 16.88 Yes 73.21 ± 21.01 32.45 ± 22.21 80.02 ± 21.22 Marital status Married 73.49 ± 21.41 30.95 ± 20.98 80.48 ± 19.43 Divorced/widowed 78.11 ± 17.77 38.75 ± 25.97 78.12 ± 26.25 Single 67.55 ± 16.19 36.47 ± 25.83 77.08 ± 15.42 Educational level Illiterate 78.66 ± 20.91* 33.05 ± 26.05 73.26 ± 28.80** Primary 77.59 ± 20.16* 30.65 ± 19.54 82.75 ± 17.58** Secondary 62.50 ± 19.60* 40.52 ± 25.45 74.51 ± 18.38** University 71.88 ± 18.46* 30.11 ± 22.02 81.96 ± 18.47** Cigarette consumption per day
Non-smoker 74.89 ± 18.83 37.01 ± 23.94** 79.63 ± 20.54 1–14 cigarettes 67.04 ± 27.97 31.69 ± 24.21** 80.35 ± 16.95 15? cigarettes 71.72 ± 22.59 25.45 ± 21.59** 76.37 ± 22.50 Former smoker 74.28 ± 18.03 30.54 ± 17.76** 82.12 ± 18.29
element in the management of diabetes to firstly ensure good glycemic control and also to reduce or delay the onset of microvascular and macrovascular complications of diabetes.
Our study showed a highly significant asso-ciation between the degree of patients’ trust in their doctor and treatment adherence. The greater the degree of confidence, the greater adherence to insulin. This result is in agreement with the study by White et al. (2013) which showed that adherence to therapy is directly proportional to the degree of patient trust in the doctor [12]. In a cross-sectional diabetes study, older patients’ evaluations of how well their physicians provided information on their ill-ness and treatment were associated with patient
self-reported medication-taking behaviors [33]. A study in the Kaiser Permanente popula-tion found that a greater proporpopula-tion of patients who failed to initiate insulin felt that their healthcare providers inadequately explained the risks and benefits of insulin, compared to those who initiated insulin [34]. More patient counseling by healthcare professionals is nee-ded to educate the patient about the possible side effects that might occur with insulin treatment and most importantly about the efficacy of insulin [34, 35]. Emphasizing the advantages of insulin treatment at the time of prescribing, as well as explaining the probability of an adverse side effect happening and its Table 5 continued
Variable Trust in physician score PAID score Adherence score Waterpipe consumption per week
Non-smoker 74.17 ± 20.33 30.67 ± 21.67* 80.62 ± 18.79** Below 3 59.74 ± 25.02 55.35 ± 21.49* 60.26 ± 33.20** 3 or more 74.14 ± 21.89 48.12 ± 20.53* 81.64 ± 23.17** Former smoker 73.18 ± 15.29 27.37 ± 21.35* 81.56 ± 13.53** Weekly alcohol consumption
Non-drinker 73.74 ± 21.08 33.24 ± 21.73 81.51 ± 19.08 Up to one time 74.91 ± 18.87 31.34 ± 24.91 75.72 ± 21.51 More than one time 64.89 ± 22.87 36.66 ± 26.85 72.57 ± 24.98 Former drinker 73.10 ± 9.89 25.41 ± 17.35 79.16 ± 18.39 Total daily dose of insulin
Delivery device Pen 73.49 ± 19.83 32.96 ± 22.11 80.22 ± 18.76 Vial 71.88 ± 22.63 30.74 ± 23.42 77.54 ± 24.69 Both 97.72 ± 0.00 65.00 ± 0.00 81.25 ± 0.00 Types of insulin One 73.24 ± 20.72 33.23 ± 22.36 78.98 ± 21.24 Two 72.88 ± 19.23 29.67 ± 22.33 82.36 ± 14.51 Three 97.72 ± 0.00 65.00 ± 0.00 81.25 ± 0.00 *p\0.05; **p[0.05 but\0.2
seriousness, may improve how patients receive information from other sources.
Our results demonstrated that the degree of patients’ trust in their physician was negatively associated with the diabetes-related distress, in line with previous findings [36] that showed that the physician effective communication behavior and a higher trust in him, as reported by the patient, were inversely related to emo-tional distress among patients with diabetes
[37]. Some interventions might be used to increase the patient’s trust in the physician; these include training interventions to improve physician behavior or providing the patients with more information about their treatment and giving them a chance to discuss options [38].
Furthermore, this study showed a significant negative association between adherence to insulin and the patient’s distress. Emotional distress was associated with poor adherence which is consistent with previous studies [39, 40]. Negative, ‘‘blocking’’ thoughts adversely impact the persons’ self-care behavior, thereby unintentionally reinforcing a negative cycle of events, which can ultimately lead to a condition referred to by Polonsky as ‘‘diabetes burnout’’ [41]. Emotional and social support were shown to increase medication adherence in diabetes [42] by increasing the patient’s active coping behavior [43]. Stronger social support from family, friends, and communities could cultivate positive mental and emotional changes. It strengthens patients’ resolve, belief, and confidence in managing their condition, and improves their quality of life [44].
Inactivity was found in our study to decrease the adherence to insulin score, in agreement with previous studies [45]. Physical activity plays a vital role in the self-management of T2DM and exercise is the best predictor of maintaining weight, and can decrease insulin resistance [46]. Fear of hypoglycemia is one of the factors that could prevent the patient from performing any physical activity. In the present study, participants with a higher awareness of hypoglycemia risk were more prone to reduce their physical activity. This is consistent with the finding of the study done in Scotland which stated that main reason for inactivity is due to fear of hypoglycemia [47].
A secondary level of education was nega-tively associated with a decrease in the trust in physician score. This might be explained by the fact that patients with higher educational attainment are more involved in the medical decision-making process and verify the credi-bility of information provided by their physi-cian and sometimes explore options beyond what is given during their medical visit [48]. Table 6 Correlation coefficients between the scores and
continuous variables Trust in physician score PAID score Adherence score Trust in physician score 1 -0.289* 0.416* PAID score -0.289* 1 -0.300* Adherence score 0.416* -0.300* 1 Age 0.078 -0.071 -0.044 BMI 0.009 0.076 -0.017 Duration of diabetes diagnosis 0.028 -0.172* 0.047 Frequency of physician’s visits 0.086 -0.031 0.081 Number of comorbidities 0.048 -0.104 -0.068 Duration of insulin therapy 0.133** -0.239* 0.000 Total insulin daily dose -0.079 0.144 0.003 Total daily number of injections -0.008 0.020 0.058 Total number of oral antidiabetics 0.167** -0.123** 0.137** *p\0.05; **p[0.05 but\0.2
People with a lower literacy level may be more willing to trust their physician and accept their recommendations without questioning them.
Smoking waterpipe was negatively associated with adherence to treatment but positively associated with the diabetes-related distress, in line with the study by Solberg et al. [49] who found that smokers with diabetes report more sadness or depression compared to non-smokers with diabetes [49]. Waterpipe smoking being associated with a decrease in adherence to treatment is similar to the findings of Ciecha-nowski et al. [50] but opposite to those of Sol-berg et al. [49].
This study also showed that patients who do not have a family history of diabetes were more adherent to insulin than patients with a family history of diabetes, in agreement with the findings of Riaz et al. [45]. This can be attributed to the higher vigilance of these patients about their disease and the fear of future complica-tions and their impact on their quality of life. On the other hand, our study showed no asso-ciation between adherence and gender, age, diabetes duration since diagnosis, and the
patient’s level of education, consistent with several previous studies [23,51–53].
Limitations
Our study has a number of limitations. The total sample size is small and might not be repre-sentative of the whole population. This is a cross-sectional self-designed survey with retro-spective reports, and consequently a low level of evidence. The effect of the recall bias could be differential and lead to the overestimation of effects for some known risk factors. An infor-mation bias is also possible since the use of a questionnaire may not always be accurate: problems in question understanding, recall deficiency, and over- or underevaluating symp-toms may still be possible. In addition, the cost of medications, a factor known to affect adher-ence, was not taken into consideration even though we think that it may not have been a strong bias in this study because 88% of the patients had either private insurance or social security paying for their medications.
Table 7 Multivariable analyses
Variable Unstandardized beta Standardized beta p value Confidence interval Linear regression 1 taking the trust in physician score as the dependent variable
Secondary level of education (compared to illiteracy) -13.486 -0.262 0.002 -21.913 - 5.059 Total number of oral antidiabetics 0.934 0.169 0.043 0.028 1.840 Linear regression 2 taking the adherence score as the dependent variable
Sedentary lifestyle -12.739 -0.232 0.006 -21.814 - 3.663 Less than 3 waterpipes per week compared to no
waterpipe smoking
-16.826 -0.188 0.027 -31.660 - 1.991
Linear regression 3 taking the PAID score as the dependent variable Less than 3 waterpipes per week compared to no
waterpipe smoking
27.426 0.273 0.001 11.221 43.632
Gender 10.467 0.234 0.005 3.267 17.667 3 or more waterpipes per week compared to no
waterpipe smoking
CONCLUSION
Patient adherence to insulin is an important criterion for achieving the desired therapeutic outcomes in diabetes management. Distress in diabetes shows a negative association with adherence. Good healthcare professional–pa-tient communication is a major expectation and an important parameter improving drug adherence. It determines the patients’ trust in their physician, thus improving adherence.
ACKNOWLEDGEMENTS
Funding. No funding or sponsorship was received for this study or publication of this article. The article processing charges were funded by the authors.
Authorship. All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published.
Thanks. The authors would like to thank all the participating pharmacies and patients.
Disclosures. Lucine Halepian, Mary Bou Saleh, Souheil Hallit, and Lydia Rabbaa Khabbaz have nothing to disclose. All authors meet the criteria for authorship and no deserving authors have been omitted.
Compliance with Ethics Guidelines. The study protocol was approved by the ethics committee of Saint-Joseph University of Beirut (reference number: USJ-2016-55). All proce-dures performed in studies involving human participants were in accordance with the ethical standards of the institutional research commit-tee of Saint-Joseph university of Beirut and with the 1964 Declaration of Helsinki and its later amendments. Informed consent was obtained from all individual participants included in the study.
Open Access. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/ by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
REFERENCES
1. Ogurtsova K, et al. IDF Diabetes Atlas: global esti-mates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:40–50. 2. World Health Organization. Diabetes.http://www.
who.int/mediacentre/factsheets/fs312/fr/. Accessed 14 July 2017.
3. Ramkisson S, Pillay BJ, Sibanda W. Social support and coping in adults with type 2 diabetes. Afr J Prim Health Care Fam Med. 2017;9(1):e1–8.
4. Sapkota S, et al. A Systematic review of interven-tions addressing adherence to anti-diabetic medi-cations in patients with type 2 diabetes-components of interventions. PLoS One. 2015;10(6):e0128581.
5. Association AD. Standards of medical care in dia-betes—2012. Diabetes Care. 2012;35(Supplement 1):S11–63.
6. NICE. 2004. Type 1 diabetes: diagnosis and man-agement of type 1 diabetes in children, young people and adults. http://www.nice.org.uk/pdf/ CG015NICEguideline.pdf. Accessed 14 July 2017. 7. National Collaborating Centre for Chronic
Condi-tions (UK), Royal College of Physicians (UK), National Institute for Health and Clinical Excel-lence. Type 2 diabetes: national clinical guideline for management in primary and secondary care (update). 2008. Royal College of Physicians (UK). 8. He X, et al. Insulin adherence and persistence
among Chinese patients with type 2 diabetes: a retrospective database analysis. Patient Pref Adher. 2017;11:237.
9. Maeda U, et al. Self-efficacy mediates the associa-tions of social support and depression with treat-ment adherence in heart failure patients. Int J Behav Med. 2013;20(1):88–96.
10. DiMatteo MR. Social support and patient adherence to medical treatment: a meta-analysis. Health Psy-chol. 2004;23(2):207–18.
11. Alazri MH, Neal RD. The association between sat-isfaction with services provided in primary care and outcomes in type 2 diabetes mellitus. Diabetes Med. 2003;20(6):486–90.
12. White RO, et al. Health literacy, physician trust, and diabetes-related self-care activities in Hispanics with limited resources. J Health Care Poor Unders. 2013;24(4):1756–68.
13. Beck RS, Daughtridge R, Sloane PD. Physician-pa-tient communication in the primary care office: a systematic review. J Am Board Fam Pract. 2002;15(1):25–38.
14. Schoenthaler AM, et al. Patient and physician fac-tors associated with adherence to diabetes medica-tions. Diabetes Educ. 2012;38(3):397–408.
15. Golin CE, et al. A diabetes-specific measure of patient desire to participate in medical decision making. Diabetes Educ. 2001;27(6):875–86. 16. Rodriguez KM. Intrinsic and extrinsic factors
affecting patient engagement in diabetes self-man-agement: perspectives of a certified diabetes edu-cator. Clin Ther. 2013;35(2):170–8.
17. Egede LE. Effects of depression on work loss and disability bed days in individuals with diabetes. Diabetes Care. 2004;27(7):1751–3.
18. Hermanns N, et al. How to screen for depression and emotional problems in patients with diabetes: comparison of screening characteristics of depres-sion questionnaires, measurement of diabetes-specific emotional problems and standard clinical assessment. Diabetologia. 2006;49(3):469–77. 19. Fisher L, et al. Clinical depression versus distress
among patients with type 2 diabetes: not just a ques-tion of semantics. Diabetes Care. 2007;30(3):542–8. 20. Fisher L, et al. Understanding the sources of
dia-betes distress in adults with type 1 diadia-betes. J Dia-betes Complicat. 2015;29(4):572–7.
21. Al-Qazaz HK, et al. The eight-item Morisky Medi-cation Adherence Scale MMAS: translation and validation of the Malaysian version. Diabetes Res Clin Pract. 2010;90(2):216–21.
22. Bell RA, et al. Correlates of physician trust among rural older adults with diabetes. Am J Health Behav. 2013;37(5):660–6.
23. Wong MC, et al. Association between the 8-item Morisky medication adherence scale (MMAS-8)
score and glycaemic control among Chinese dia-betes patients. J Clin Pharmacol. 2015;55(3):279–87.
24. Lu M, et al. Optimal recall period and response task for self-reported HIV medication adherence. AIDS Behav. 2008;12(1):86–94.
25. Preston CC, Colman AM. Optimal number of response categories in rating scales: reliability, validity, discriminating power, and respondent preferences. Acta Psychol (Amst). 2000;104(1):1–15. 26. Garfield S, et al. Developing the Diagnostic Adher-ence to Medication Scale (the DAMS) for use in clinical practice. BMC Health Serv Res. 2012;12:350. 27. Kalsingh MJ, Veliah G, Gopichandran V. Psycho-metric properties of the Trust in Physician Scale in Tamil Nadu, India. J Family Med Prim Care. 2017;6(1):34–8.
28. Dong X, Bergren S, Simon MA. Cross-sectional and longitudinal association between trust in physician and depressive symptoms among U.S. community-dwelling Chinese older adults. J Gerontol A Biol Sci Med Sci. 2017;72(suppl_1):125–30.
29. Alimena S, Air ME. Trust, satisfaction, and confi-dence in health care providers among student and professional dancers in France. Med Probl Perform Art. 2016;31(3):166–73.
30. Lobo CP, et al. Impact of invalidation and trust in physicians on health outcomes in fibromyalgia patients. Prim Care Companion CNS Disord. 2014;16(5).https://doi.org/10.4088/PCC.14m01664. 31. Anderson LA, Dedrick RF. Development of the Trust in Physician scale: a measure to assess interpersonal trust in patient-physician relationships. Psychol Rep. 1990;67(3 Pt 2):1091–100.
32. Welch GW, Jacobson AM, Polonsky WH. The problem areas in diabetes scale. an evaluation of its clinical utility. Diabetes Care. 1997;20(5):760–6. 33. Heisler M, et al. Does physician communication
influence older patients’ diabetes self-management and glycemic control? Results from the Health and Retirement Study (HRS). J Gerontol Ser A Biol Sci Med Sci. 2007;62(12):1435–42.
34. Karter AJ, et al. Barriers to insulin initiation: the translating research into action for diabetes insulin starts project. Diabetes Care. 2010;33(4):733–5. 35. Forum for Injection Technique. The UK Injection
Technique Recommendations, 3rd edn. 2015.
http://www.fit4diabetes.com/files/6714/4293/6325 /FIT_Injection_Technique_Recommendations_3rd_ Edition_lo_res.pdf. Accessed 14 July 2017.
36. Slean GR, et al. Aspects of culturally competent care are associated with less emotional burden among patients with diabetes. Med Care. 2012;50(9 Suppl 2):S69–73.
37. Rubin DJ, McDonnell ME. Effect of a diabetes cur-riculum on internal medicine resident knowledge. Endocr Pract. 2010;16(3):408–18.
38. Rolfe A, et al. Interventions for improving patients’ trust in doctors and groups of doctors. Cochrane Database Syst Rev. 2014(3):CD004134.
39. Kumar N, Unnikrishnan B, Rekha T, Mithra P, Kulkarni V, Holla R, Bhagawan D, Kumar A, Aithal S (2017) Distress and Its effect on adherence to antidiabetic medications among type 2 diabetes patients in Coastal South India. J Nat Sci Biol Med 8(2):216–20.
40. Aikens JE (2012) Prospective Associations Between Emotional Distress and Poor Outcomes in Type 2 Diabetes. Diabetes Care 35(12):2472–8.
41. Polonsky W. Understanding and treating patients with diabetes burnout. Practical psychology for diabetes clinicians. Alexandria: American Diabetes Association; 1996. p. 183–92.
42. Schiotz ML, et al. Social support and self-manage-ment behaviour among patients with type 2 dia-betes. Diabet Med. 2012;29(5):654–61.
43. Kanbara S, et al. Social support, self-efficacy and psychological stress responses among outpatients with diabetes in Yogyakarta, Indonesia. Diabetes Res Clin Pract. 2008;80(1):56–62.
44. Shao Y, et al. The effect of social support on gly-cemic control in patients with type 2 diabetes mellitus: the mediating roles of self-efficacy and adherence. J Diabetes Res. 2017;2017:2804178.
45. Riaz M, et al. Factors associated with non-adherence to insulin in patients with type 1 diabetes. Pak J Med Sci. 2014;30(2):233.
46. Ulvi OS, et al. Investigating the awareness level about diabetes mellitus and associated factors in Tarlai (rural Islamabad). J Pak Med Assoc. 2009;59(11):798–801.
47. Mayer-Davis EJ, et al. Dietary intake among youth with diabetes: the SEARCH for Diabetes in Youth Study. J Am Diet Assoc. 2006;106(5):689–97. 48. Smith SK, et al. Exploring patient involvement in
healthcare decision making across different educa-tion and funceduca-tional health literacy groups. Soc Sci Med. 2009;69(12):1805–12.
49. Solberg LI, et al. Diabetic patients who smoke: are they different? Ann Fam Med. 2004;2(1):26–32. 50. Ciechanowski PS, Katon WJ, Russo JE. Depression
and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med. 2000;160(21):3278–85.
51. Farsaei S, et al. Insulin adherence in patients with diabetes: risk factors for injection omission. Primary Care Diabetes. 2014;8(4):338–45.
52. Aikens JE, Piette JD. Longitudinal association between medication adherence and glycaemic control in type 2 diabetes. Diabet Med. 2013;30(3):338–44.
53. Manan MM, et al. Interplay between oral hypo-glycemic medication adherence and quality of life among elderly type 2 diabetes mellitus patients. J Clin Diagn Res. 2014;8(12):JC05–9.
